Total Funding
8
Total FundingPost-IPO Equity raised
Growth Score
pts
Heat Score
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
877567
Synageva, a biopharmaceutical company, develops and commercializes novel, next generation and follow on protein therapeutics.
Acquired by 
Alexion Pharmaceuticals
- Stephen R. Biggar: DirectorPast Role: Baker Brothers Advisors LLC, Principal
About the Company
Synageva is a biopharmaceutical company dedicated to developing and commercializing novel, next generation and follow on protein therapeutics that leverage the unique competitive advantages of their proprietary Synageva Expression Platform (SEPTM).
